Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit is currently disabled

Estefania Roldan, M.D.

Concepts (12)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Estefania Roldan's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Estefania Roldan has written about over time.
Antineoplastic Combined Chemotherapy Protocols, 1 publications between 2023 and 2023, average publication date August 2023. Chemotherapy, Adjuvant, 1 publications between 2023 and 2023, average publication date August 2023. Lymph Nodes, 2 publications between 2023 and 2023, average publication date September 2023. Neoadjuvant Therapy, 2 publications between 2023 and 2023, average publication date September 2023. Lymph Node Excision, 1 publications between 2023 and 2023, average publication date October 2023. Lymphatic Metastasis, 1 publications between 2023 and 2023, average publication date October 2023. Sentinel Lymph Node Biopsy, 1 publications between 2023 and 2023, average publication date October 2023. Axilla, 3 publications between 2023 and 2023, average publication date October 2023. Breast Neoplasms, 3 publications between 2023 and 2023, average publication date October 2023. Female, 3 publications between 2023 and 2023, average publication date October 2023. Humans, 3 publications between 2023 and 2023, average publication date October 2023. Breast, 1 publications between 2023 and 2023, average publication date December 2023.

To see the data from this visualization as text, click here.
Roldan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (12)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.